» Articles » PMID: 16738315

The SUMO-specific Protease SENP5 is Required for Cell Division

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2006 Jun 2
PMID 16738315
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Posttranslational modification of substrates by the small ubiquitin-like modifier, SUMO, regulates diverse biological processes, including transcription, DNA repair, nucleocytoplasmic trafficking, and chromosome segregation. SUMOylation is reversible, and several mammalian homologs of the yeast SUMO-specific protease Ulp1, termed SENPs, have been identified. We demonstrate here that SENP5, a previously uncharacterized Ulp1 homolog, has SUMO C-terminal hydrolase and SUMO isopeptidase activities. In contrast to other SENPs, the C-terminal catalytic domain of SENP5 preferentially processed SUMO-3 compared to SUMO-1 precursors and preferentially removed SUMO-2 and SUMO-3 from SUMO-modified RanGAP1 in vitro. In cotransfection assays, SENP5 preferentially reduced high-molecular-weight conjugates of SUMO-2 compared to SUMO-1 in vivo. Full-length SENP5 localized to the nucleolus. Deletion of the noncatalytic N-terminal domain led to loss of nucleolar localization and increased de-SUMOylation activity in vivo. Knockdown of SENP5 by RNA interference resulted in increased levels of SUMO-1 and SUMO-2/3 conjugates, inhibition of cell proliferation, defects in nuclear morphology, and appearance of binucleate cells, revealing an essential role for SENP5 in mitosis and/or cytokinesis. These findings establish SENP5 as a SUMO-specific protease required for cell division and suggest that mechanisms involving both the catalytic and noncatalytic domains determine the distinct substrate specificities of the mammalian SUMO-specific proteases.

Citing Articles

Peptidylprolyl isomerase A guides SENP5/GAU1 DNA-lncRNA triplex generation for driving tumorigenesis.

Zhang X, Ding T, Yang F, Zhang J, Xu H, Bai Y Nat Commun. 2024; 15(1):9068.

PMID: 39433793 PMC: 11494105. DOI: 10.1038/s41467-024-53493-x.


Exploring potential targets for natural product therapy of DN: the role of SUMOylation.

Wang J, Zhang R, Wu C, Wang L, Liu P, Li P Front Pharmacol. 2024; 15:1432724.

PMID: 39431155 PMC: 11486755. DOI: 10.3389/fphar.2024.1432724.


Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma.

Lu K, Zhang M, Qin H, Shen S, Song H, Jiang H Acta Pharm Sin B. 2024; 14(7):2977-2991.

PMID: 39027231 PMC: 11252481. DOI: 10.1016/j.apsb.2024.03.013.


Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.

Huang C, Yang T, Lin K J Biomed Sci. 2024; 31(1):16.

PMID: 38280996 PMC: 10821541. DOI: 10.1186/s12929-024-01003-y.


SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation.

Liu T, Wang H, Chen Y, Wan Z, Du Z, Shen H J Exp Clin Cancer Res. 2023; 42(1):234.

PMID: 37684630 PMC: 10486113. DOI: 10.1186/s13046-023-02789-9.


References
1.
Nishida T, Tanaka H, Yasuda H . A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur J Biochem. 2000; 267(21):6423-7. DOI: 10.1046/j.1432-1327.2000.01729.x. View

2.
Sui G, Shi Y . Gene silencing by a DNA vector-based RNAi technology. Methods Mol Biol. 2005; 309:205-18. DOI: 10.1385/1-59259-935-4:205. View

3.
Taylor D, Ho J, Oliver A, Watts F . Cell-cycle-dependent localisation of Ulp1, a Schizosaccharomyces pombe Pmt3 (SUMO)-specific protease. J Cell Sci. 2002; 115(Pt 6):1113-22. DOI: 10.1242/jcs.115.6.1113. View

4.
Hang J, Dasso M . Association of the human SUMO-1 protease SENP2 with the nuclear pore. J Biol Chem. 2002; 277(22):19961-6. DOI: 10.1074/jbc.M201799200. View

5.
Zhang H, Saitoh H, Matunis M . Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell Biol. 2002; 22(18):6498-508. PMC: 135644. DOI: 10.1128/MCB.22.18.6498-6508.2002. View